Search in:

Journal of Market Access & Health Policy Volume 3, 2015 - Issue 1

Journal homepage

Open access

1,446

Views

CrossRef citations to date

Altmetric

Debate Pieces

Current process and future path for health economic assessment of pharmaceuticals in France

Mondher ToumiFaculté de Médecine, Laboratoire de Santé Publique, Aix-Marseille Université, Université de la Méditerranée, Marseille Cedex, FranceCorrespondence[email protected]

(Professor) ,

Cécile Rémuzat Creativ-Ceutical Paris, France

, PharmD,

Emna El Hammi Evidenz Tunis, Tunisia

, PhD,

Aurélie Millier Creativ-Ceutical Paris, France

, PhD,

Samuel Aballéa Creativ-Ceutical Paris, France

, MSc,

Christos ChouaidINSERM U955 and Université Paris Est (UPEC), UMR U955, Faculté de médecine, F-94010, Créteil, France;Centre Hospitalier Intercommunal, DHU-ATVB, Département de Pneumologie et Pathologie Professionnelle, F-94000, Créteil, France

(Professor) &

Bruno FalissardINSERM Unit U669 (Public Health and Mental Health)University Paris-Sud, Maison de Solenn, Paris, France

(Professor) show all

Article: 27902 | Received 18 Mar 2015, Accepted 15 Apr 2015, Published online: 04 Jun 2015

Cite this article
https://doi.org/10.3402/jmahp.v3.27902
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Law no 2007-1786 of social security funding for 2008. 2007. Available from: http://www.legifrance.gouv.fr/affichTexteArticle.do;jsessionid=A51124210A870B450651619B3FE0765E.tpdjo17v_2?idArticle=JORFARTI000017726750&cidTexte=JORFTEXT000017726554&dateTexte=29990101&categorieLien=id [cited 19 December 2007]..
Google Scholar
Law no 2011-1906 of social security funding for 2012. 2011. Available from: http://www.legifrance.gouv.fr/affichTexteArticle.do;jsessionid=A51124210A870B450651619B3FE0765E.tpdjo17v_2?idArticle=JORFARTI000025006191&cidTexte=JORFTEXT000025005833&dateTexte=29990101&categorieLien=id [cited 21 December 2011]..
Google Scholar
Social Security report. 2004. Available from: http://www.ladocumentationfrancaise.fr/var/storage/rapports-publics/044000453/0001.pdf [cited 6 January 2015]..
Google Scholar
HAS. 2011. Activity report 2011. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/rapport_activite_has_2011.pdf [cited 8 January 2015]..
Google Scholar
HAS. The Economic and Public Health Assessment Committee (CEESP). 2014. Available from: http://www.has-sante.fr/portail/jcms/c_419565/fr/commission-evaluation-economique-et-de-sante-publique [cited 11 January 2015]..
Google Scholar
HAS. Rules of procedure of the Economic and Public Health Assessment Committee. 2014. Available from: http://www.has-sante.fr/portail/jcms/c_419565/fr/commission-evaluation-economique-et-de-sante-publique [cited 6 January 2015]..
Google Scholar
Ministère des Affaires Sociales de la Santé et des Droits des Femmes. Comité Economique des Produits de Santé (CEPS). 2014. Available from: http://www.sante.gouv.fr/comite-economique-des-produits-de-sante-ceps.html [cited 8 January 2015]..
Google Scholar
HAS. Production of economic opinion on drugs and medical devices in France: Challenges and issues. 2014; Washington, DC: HTAi.
Google Scholar
Legifrance. Decree no 2012-1116 of October 2, 2012 related to the medico-economic missions of the HAS. Available from: http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000026453514&categorieLien=id [cited 8 January 2015]. .
Google Scholar
HAS. Decision no 2013.0111/DC/SEESP of September 18, 2013 of the HAS College related to the significant impact on the health insurance expenses, triggering the medico-economic evaluation of the products claiming ASMR or ASA levels from level I to III. 2013. Available from: http://has-sante.fr/portail/jcms/c_1647592/fr/decision-n20130111/dc/seesp-du-18-septembre-2013-du-college-de-la-has-relatif-a-limpact-significatif-sur-les-depenses-de-lassurance-maladie-declenchant-levaluation-medico-economique-des-produits-revendiquant-une-asmr-ou-une-asa-de-niveaux-i-ii-ou-iii [cited 9 January 2015]..
Google Scholar
HAS. Methodological guidance. 2011. Methodological choices for the economic evaluation at the HAS. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-11/guide_methodo_vf.pdf [cited 12 January 2015]..
Google Scholar
HAS. Opinion of cost-effectiveness. Deposit Notice July 2013. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-08/notice_de_depot.pdf [cited 13 January 2015]..
Google Scholar
Avis d'efficience – Rapport de presentation. Available from: http://www.has-sante.fr/portail/jcms/c_1627029/fr/rapport-de-presentation-type [cited 15 January 2015]..
Google Scholar
HAS. Opinion of cost-effectiveness. 2013. Preparatory file in view of early meeting with the Economic Evaluation and Public Health Service. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-07/rp_dossier_eco_130716.pdf [cited 14 January 2015]..
Google Scholar
HAS. Opinion of cost-effectiveness. 2013. Elaboration steps. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-08/etapes_delaboration_des_avis_defficience.pdf [cited 6 January 2015]..
Google Scholar
HAS. Opinion of cost-effectiveness. 2013. Opinion of cost-effectiveness format. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-08/format_de_lavis.pdf [cited 13 January 2015]..
Google Scholar
Rémuzat C , Toumi M , Falissard B . New drug regulations in France: what are the impacts on market access? Part 2 impacts on market access and impacts for the pharmaceutical industry. J Market Access Health Policy. 2013; 1: 20892. doi: http://dx.doi.org/10.3402/jmahp.v1i0.20892 .
Google Scholar
HAS 2014-Dossier de presse-L’évaluation médico-économique des médicaments et dispositifs médicaux, Service presse, décembre. 2014. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-12/dossier_presse_evaluation_medico_eco.pdf [cited 16 January 2015]..
Google Scholar
HAS- Report of activity. (Rapport d'activité 2013). 2013. Available from: http://www.has-sante.fr/portail/jcms/c_1267546/fr/rapport-annuel-d-activite-2013 [cited 17 January 2015]..
Google Scholar
Meeting HAS-AMIPS. The HAS in the new health environment in France and Europe. 2012. Available from: http://www.amips.fr/media/documents/presse/apm-040212_1354786239.pdf [cited 17 January 2015]..
Google Scholar
Economic Committee on Healthcare Products. Report of activity. 2014. Available from: http://www.sante.gouv.fr/IMG/pdf/Rapport_d_activite_du_CEPS_en_2013_version_francaise_.pdf [cited 12 January 2015]..
Google Scholar
HAS- Report of activity. (Rapport d'activité 2011). 2011. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/rapport_activite_has_2011.pdf [cited 13 January 2015]..
Google Scholar
Guidance letter of 2 April 2013 from the Ministers to the President of the CEPS. Available from: http://www.sante.gouv.fr/IMG/pdf/Lettre_d_orientation_des_ministres_du_2_avril_2013.pdf [cited 18 January 2015]..
Google Scholar
Framework Agreement 2012–2015 between the CEPS and the LEEM (“les Entreprises du Médicament”). Available from: http://www.sante.gouv.fr/IMG/pdf/Lettre_d_orientation_des_ministres_du_2_avril_2013.pdf [cited 18 January 2015]..
Google Scholar
IGAS, Rapport n°2014-066R – Evaluation médico-économique en santé. Available from: http://www.igas.gouv.fr/IMG/pdf/2014-066R_-_Rapport_DEF.pdf [cited 14 January 2015]..
Google Scholar
Buxton MJ , Drummond MF , Van Hout BA , Prince RL , Sheldon TA , Szucs T et al. Modelling in economic evaluation: An unavoidable fact of life. Health Econ. 1997; 6(3): 217–27.
PubMed Web of Science ®Google Scholar
Claxton K , Martin S , Soares M , Rice N , Spackman E , Hinde S . Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess. 2015; 19(4): 1–503.
PubMed Web of Science ®Google Scholar
HAS. Valeurs de références pour l’évaluation économique en santé. Revue de la literature. 2014. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-12/valeurs_de_reference_vf.pdf [cited 16 January 2015]..
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Current process and future path for health economic assessment of pharmaceuticals in France

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Current process and future path for health economic assessment of pharmaceuticals in France

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date